Angiocrine Bioscience
PrivateLast Round
VC Round
Sep 4, 2025
Total Funding Raised
$43.73M
Company Overview
Angiocrine Bioscience is a biotechnology company that develops a curative cellular therapies platform aimed at treating conditions in regenerative medicine and hematopoietic stem cell gene therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Angiocrine Bioscience Comps
Public and private peers based on sector, stage, and business model.
Angiocrine Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 4, 2025 | ||||
| Grant | Dec 19, 2022 | ||||
| Grant | Dec 15, 2022 | ||||
| Series B | Mar 29, 2022 | ||||
| Grant | Aug 24, 2017 | ||||
Grant | Feb 23, 2017 |
Angiocrine Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Growth Capital | Series B |
| California Institute for Regenerative Medicine | Grant |
| Cobro Ventures | Series B |
Angiocrine Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Angiocrine Bioscience's valuation, stock price, and market status.
